Pharmacotherapy of cardiovascular comorbidities in osteoporotic postmenopausal women
Abstrak
Aim: to assess tolerability and efficacy of cardiovascular comorbidities pharmacotherapy in osteoporotic postmenopausal women. Methods: cross-sectional study included 112 osteoporotic postmenopausal women aged from 49 to 85. Results: 95 persons (84.8%) had indications for angiotensine-convertising enzyme inhibitors (ACEI) prescription. Cough was associated with significantly higher odds of coronary heart disease, congestive heart failure and a trend to multiple bone fractures. Valsartan was initiated in 32 coughing patients. Target blood pressure level was reached in 15 women. In 15 cases blood pressure levels decreased by 30% of baseline level. Conclusion: efficacy of cardiovascular diseases in osteoporotic postmenopausal women treatment needs to be assessed in specially designed clinical trials.
Topik & Kata Kunci
Penulis (2)
Nadezhda V. Izmozherova
Artem A. Popov
Akses Cepat
- Tahun Terbit
- 2017
- Sumber Database
- DOAJ
- DOI
- 10.14341/osteo2017117-21
- Akses
- Open Access ✓